France Pharmaceuticals and Healthcare Report Q2 2009 – New Company …

Jun 23rd, 2009 | By French BioBeach | Category: Latests News and Alerts

PR-Inside.com (Pressemitteilung) – Wien,Austria
France Biotech’s Drug Pipeline Review, published in March 2009, revealed that funding for the country’s life sciences industry fell to EUR143mn (US$180mn) …

France Pharmaceuticals and Healthcare Report Q2 2009 – New Company …

Posted via email from French BioBeach

Share this:
  • Digg
  • del.icio.us
  • Facebook
  • FriendFeed
  • LinkedIn
  • MySpace
  • Reddit
  • StumbleUpon
  • TwitThis

Related posts:

  1. France Set To Lead The Growth Of The European Active Pharmaceuticals Ingredients Market
  2. European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health Issues
  3. France Biotech elects new chair to succeed Pouletty
  4. US biofuel makers want CO2 credits in climate bill – Reuters
  5. biotechs see light at end of funding tunnel

Tags:

Leave Comment